Table 1.
Pharmacotherapy Levels for CRD Based on Medication Dose as Defined by a Clinical Consensus Panel
| SAB | Low dose ICSa | Medium dose ICS±LABa | High dose ICS±LAB±OSa |
|---|---|---|---|
| Terbutaline AND/OR | <250 μg Beclomethasone AND/OR | 250–500 μg Beclomethasone AND/OR | >500 μg Beclomethasone AND/OR |
| Salbutamol AND/OR | <400 μg Budesonide AND/OR | 400–800 μg Budesonide AND/OR | >800 μg Budesonide AND/OR |
| Ipratropium AND/OR | <250 μg Fluticasone | 250–500 μg Fluticasone | >500 μg Fluticasone |
| Tiotropium AND/OR | AND/OR | ||
| Nedocromil | Eformoterol AND/OR | Eformoterol AND/OR | |
| Salmeterol | Salmeterol | ||
| AND/OR | |||
| >1 prescription per year of hydrocortisone and/or prednisolone | |||
SAB = short-acting bronchodilators
ICS = inhaled corticosteroids
LAB = long-acting bronchodilators
OS = oral steriods
aDoses represent daily doses